Elan to sell Westmeath unit to US firm, 400 jobs 'safe'

Athlone-based pharmaceutical company Elan is selling its Westmeath unit to US biotechnology firm Alkermes.

Mon, 09 May, 2011 - 13:23

Athlone-based pharmaceutical company Elan is selling its Westmeath unit to US biotechnology firm Alkermes.

It is understood Elan will be retaining a 25% share in the business, which employs 400 staff in Athlone.

You have reached your article limit. Already a subscriber? Sign in

Unlimited access starts here.

Try from only €0.25 a day.

Cancel anytime

CONNECT WITH US TODAY

Whatsapp logo

WHATSAPP

Newsletter logo

NEWSLETTERS

Notification logo

NOTIFICATIONS

Be the first to know the latest news and updates

More in this section

Minister urges delay to water works in period of ‘extreme heat’ Minister urges delay to water works in period of ‘extreme heat’
'At least they'll have someone to converse with': Only two pupils enrolled in new gaelcholáiste 'At least they'll have someone to converse with': Only two pupils enrolled in new gaelcholáiste
Paediatrician doctor examining a young female patient sitting on her mothers lap wearing masks. 'Parents forced to take State to court for services and even diagnoses for their children'
CourtsHeathrowPlace: USPlace: AthlonePerson: TDPerson: Nicky McFaddenOrganisation: ElanOrganisation: AthloneOrganisation: AlkermesOrganisation: Alkermes PLCOrganisation: Elan Drug TechnologiesOrganisation: Midlands 103
<p>Ronan Lorcan (left) making the most of the sunny weather at Aghada Pier, Co Cork. Picture: Larry Cummins</p>

Heat warning extended as Ireland's all-time temperature record could be broken today

READ NOW

Lunchtime News

Newsletter

Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.

Latest

Most Read

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited